patentsboard

99 results found.

Top Stocks matching your search for "patents board"

Click Learn More to know about Stock Advisor's top picks. We've 3x'd the S&P 500 over the last 20 years.

02/1002/1502/2102/2403/0103/0603/0903/1403/1703/22
SLRX

Salarius Pharmaceuticals Inc

-8.52%

$2.23 - $2.04

Feb 8th 2023 - Mar 22nd 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

No reviews available.

02/1002/1502/2102/2403/0103/0603/0903/1403/1703/22
RSLS

ReShape Lifesciences Inc.

-48.86%

$5.91 - $3.02

Feb 8th 2023 - Mar 22nd 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Feb, 17, 2023

$RSLS patent, approved, patent approved, patent ap... See more

Feb, 17, 2023

$RSLS it’s a great squeeze scenario, fill the $12 ... See more

02/1002/1502/2102/2403/0103/0603/0903/1403/1703/22
AUPH

Aurinia Pharmaceuticals Inc

3.07%

$8.48 - $8.74

Feb 8th 2023 - Mar 22nd 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Mar, 16, 2023

Sales improving, patent safe, patent extension 203... See more

Mar, 14, 2023

That together with no competition in the field, pa... See more

SLRX

Salarius Pharmaceuticals Inc

-8.52%

$2.23 - $2.04

Feb 8th 2023 - Mar 22nd 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

No reviews available.

RSLS

ReShape Lifesciences Inc.

-48.86%

$5.91 - $3.02

Feb 8th 2023 - Mar 22nd 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Feb, 17, 2023

$RSLS patent, approved, patent approved, patent approved…it’s going up up and away

Feb, 17, 2023

$RSLS it’s a great squeeze scenario, fill the $12 daily gap, and don’t forget the patent

Feb, 17, 2023

$RSLS great patent and more news coming

Feb, 17, 2023

$RSLS nice formation, great, volume, strong rsi, and let’s not forget patent was approved

Feb, 17, 2023

$RSLS The good old patent pump! 😂

AUPH

Aurinia Pharmaceuticals Inc

3.07%

$8.48 - $8.74

Feb 8th 2023 - Mar 22nd 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Mar, 16, 2023

Sales improving, patent safe, patent extension 2037, increase in insurance covering.

Mar, 14, 2023

That together with no competition in the field, patent life, IPR out of the way is a mix of cocktails that favors BO.

Mar, 10, 2023

Blockbuster drug with improving sales and long patent life

Mar, 1, 2023

$AUPH patent is safe.

Feb, 6, 2023

It was easy when you had that patent lock on you.

Feb, 6, 2023

The patent challenges are now over and IP protection is very solid.

Feb, 1, 2023

$AUPH The BBT TRX/NRX numbers are showing a significant jump, the patent challenges are over and new patents solidify the IP, the revenue outlook Peter provided is obviously very easy to beat, especially if TRX/NRX numbers continue high.

Jan, 31, 2023

Anyway, the Patent’s they filed for again Europe and US, what’s the guess for approval and think that would be a big plus on BO.